Last reviewed · How we verify
NCT04821492
Relationship Between Homocysteine and BMD
trial testing Dual-Energy X-ray Absorptiometry (DXA) in Postmenopausal Women in 760 participants. Completed in 31 March 2020.
31 March 2020
Quick facts
| Lead sponsor | Fundación Santiago Dexeus Font |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 760 |
| Start date | 1 April 2019 |
| Primary completion | 31 March 2020 |
| Estimated completion | 31 March 2020 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Dual-Energy X-ray Absorptiometry (DXA)
Conditions studied
- Postmenopausal Women — all drugs for Postmenopausal Women →
Sponsor
Fundación Santiago Dexeus Font — full company profile →
Who can join
50 and older, female only, with Postmenopausal Women. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The association between Homocysteine (Hcy) levels and bone mineral density (BMD) has been debated. Some studies have found a relationship between increased Hcy plasma levels and BMD in contrast; other studies have not found a relationship. The purpose of our study was to investigate whether or not Hcy plasma levels are related to BMD in a group of postmenopausal women.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04821492
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Postmenopausal Women
Currently open trials in the same condition.
- NCT07385534 — Effects of Lower Body EMS Training in Postmenopausal Women · NA · recruiting
- NCT06789900 — Everolimus and/or Exercise to Prevent Bone Loss in Postmenopausal Women · Phase 2 · active not recruiting
- NCT06042673 — Impact of Pomegranate Seed Oil on Postprandial Cardiovascular Disease Risk Markers · NA · recruiting
- NCT03705845 — Tocotrienols for Obesity of Postmenopausal Women · Phase 1, PHASE2 · active not recruiting
Other Fundación Santiago Dexeus Font trials
Trials by the same sponsor.
- NCT06134479 — Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation. · Phase 3 · completed
- NCT06154083 — INtensity of OVarian Stimualtion and Euploid Embryos · Phase 4 · recruiting
- NCT04983173 — INTEnsity of ovariaN Stimulation and Embryo Quality · Phase 4 · completed
- NCT04992468 — Dual Trigger for Elective Fertility Preservation · Phase 4 · completed
- NCT04446845 — Double Stimulation Followed by a Fresh Embryo Transfer · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04821492 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundación Santiago Dexeus Font
- Last refreshed: 28 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04821492.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing